Research confirms that obstructive sleep apnea is linked to sarcopenia, or muscle loss, specifically in older adults, with the risk increasing with age and disease severity.
Read the full answer →
CPAP produces the largest reduction in apnea-hypopnea index (AHI), while GLP-1 medications improve weight and metabolic health in OSA patients.
Read the full answer →
Yes, people with obstructive sleep apnea show impaired brain fluid flow (glymphatic dysfunction) compared to healthy controls, as measured by MRI-based markers.
Read the full answer →
A 2025 simulation study found tirzepatide cost-effective vs semaglutide for obesity, including OSA risk, but no direct cost comparison for OSA alone exists.
Read the full answer →
Yes, childhood asthma is linked to a higher risk of developing obstructive sleep apnea later, with studies showing about 66% increased odds.
Read the full answer →